Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Tal BurtRobert J Noveck

Abstract

Intraarterial microdosing (IAM) is a novel drug development approach combining intraarterial drug delivery and microdosing. We aimed to demonstrate that IAM leads to target exposure similar to that of systemic full-dose administration but with minimal systemic exposure. IAM could enable the safe, inexpensive, and early study of novel drugs at the first-in-human stage and the study of established drugs in vulnerable populations. Insulin was administered intraarterially (ipsilateral femoral artery) or systemically to 8 CD IGS rats just before blood sampling or 60-min (18)F-FDG uptake PET imaging of ipsilateral and contralateral leg muscles (lateral gastrocnemius) and systemic muscles (spinotrapezius). The (18)F-FDG uptake slope analysis was used to compare the interventions. Plasma levels of insulin and glucose were compared using area under the curve calculated by the linear trapezoidal method. A physiologically based computational pharmacokinetics/pharmacodynamics model was constructed to simulate the relationship between the administered dose and response over time. (18)F-FDG slope analysis found no difference between IAM and systemic full-dose slopes (0.0066 and 0.0061, respectively; 95% confidence interval [CI], -0.024 to 0....Continue Reading

Associated Clinical Trials

References

Mar 4, 2003·Nature Reviews. Drug Discovery·Graham Lappin, R Colin Garner
Aug 26, 2003·European Journal of Clinical Pharmacology·Mats BergströmBengt Långström
Apr 9, 2005·Physics in Medicine and Biology·Patrick L ChowArion F Chatziioannou
Jul 5, 2005·Drug Discovery Today·Ian R Wilding, J Angus Bell
Mar 29, 2007·Journal of Clinical Pharmacology·Joseph S BertinoUNKNOWN American College of Clinical Pharmacology
May 4, 2007·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hsiao-Ming WuSung-Cheng Huang
Aug 6, 2008·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Chris SuckowDavid Stout
Sep 23, 2008·American Journal of Therapeutics·Kenneth A GetzKenneth I Kaitin
Dec 4, 2008·Fundamental & Clinical Pharmacology·Luc Zimmer
Dec 2, 2009·Nature Reviews. Drug Discovery·Bernard Munos
Feb 5, 2010·Clinical Pharmacology and Therapeutics·J A DiMasiA Wilson
Feb 20, 2010·Nature Reviews. Drug Discovery·Steven M PaulAaron L Schacht
Apr 3, 2010·PLoS Medicine·H Bart van der WorpMalcolm R Macleod
Apr 7, 2010·Science Translational Medicine·Barry S Coller, Robert M Califf
Oct 5, 2010·Advanced Drug Delivery Reviews·Claudia C Wagner, Oliver Langer
Oct 19, 2010·Advanced Drug Delivery Reviews·Yuichi Sugiyama, Shinji Yamashita
Feb 25, 2011·Advanced Drug Delivery Reviews·Kazuya Maeda, Yuichi Sugiyama
Jun 2, 2011·Nature Reviews. Drug Discovery·Fabio PammolliMassimo Riccaboni
Jul 8, 2011·Science Translational Medicine·Francis S Collins
Feb 18, 2012·Clinical Pharmacokinetics·Marie CroftGraham Lappin
Mar 2, 2012·Nature Reviews. Drug Discovery·Jack W ScannellBrian Warrington
Sep 14, 2012·Drug Metabolism and Pharmacokinetics·Naoe YamaneYuichi Sugiyama
Apr 5, 2013·Expert Opinion on Drug Metabolism & Toxicology·Graham LappinTal Burt
Nov 7, 2013·Clinical Pharmacology and Therapeutics·R Kaddurah-DaoukUNKNOWN Pharmacometabolomics Research Network
Jan 11, 2014·Frontiers in Neuroenergetics·Kimberly R ByrnesReed G Selwyn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.